Novel targeted immunotherapy approaches for staphylococcal infection

Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men

(2013) Binh An Diep et al.   ANNALS OF INTERNAL MEDICINE

Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils

(2010) Bettina Löffler et al.   PLoS Pathogens

Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections, in Very-Low-Birth-Weight Neonates

(2009) L. E. Weisman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against Staphylococcus aureus Pneumonia

(2009) B. E. Ragle et al.   INFECTION AND IMMUNITY

Staphylococcal Vaccines and Immunotherapies

(2009) Adam C. Schaffer et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects

(2009) T. Coates et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era

(2009) Frank R. DeLeo et al.   JOURNAL OF CLINICAL INVESTIGATION

Invasive Infection Caused by a Community-Associated Methicillin-ResistantStaphylococcus aureusStrain Not Carrying Panton-Valentine Leukocidin in South Korea : TABLE 1.

(2009) Seung Soon Lee et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Phenol‐Soluble Modulin α3 Enhances the Human Neutrophil Lysis Mediated by Panton‐Valentine Leukocidin

(2009) Isamu Hongo et al.   JOURNAL OF INFECTIOUS DISEASES

Waves of resistance: Staphylococcus aureus in the antibiotic era

(2009) Henry F. Chambers et al.   NATURE REVIEWS MICROBIOLOGY

Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Associated with Pediatric Infection in Cambodia

(2009) Kheng Chheng et al.   PLoS One

Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France, 2002–2007

(2009) Elifsu Sabuncu et al.   PLOS MEDICINE

The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300

(2008) E.L. Brown et al.   CLINICAL MICROBIOLOGY AND INFECTION

The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus

(2008) B. Spellberg et al.   INFECTION AND IMMUNITY

Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia

(2008) Graeme R. Nimmo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

An antidote forStaphylococcus aureuspneumonia?

(2008) Frank R. DeLeo et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Vaccine protection againstStaphylococcus aureuspneumonia

(2008) Juliane Bubeck Wardenburg et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Epidemiology of community-acquired meticillin-resistant Staphylococcus aureus obtained from the UK West Midlands region

(2008) J. Rollason et al.   JOURNAL OF HOSPITAL INFECTION

Panton‐Valentine Leukocidin Is Not a Virulence Determinant in Murine Models of Community‐Associated Methicillin‐ResistantStaphylococcus aureusDisease

(2008) Juliane Bubeck Wardenburg et al.   JOURNAL OF INFECTIOUS DISEASES

The role of virulence determinants in community-associated MRSA pathogenesis

(2008) Binh An Diep et al.   TRENDS IN MICROBIOLOGY